Dr. Charles T. Dewberry, DO

Dr. Dewberry practices at Florida Dermatology & Skin Cancer Centers in Winter Haven, Florida.

Dr. Dewberry's NPI, 1992728802, was assigned on July 25, 2006. Dr. Dewberry graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 2000. Dr. Dewberry holds Florida license OS8732.

Dr. Dewberry's primary practice is Florida Dermatology & Skin Cancer Centers, at 1450 6th SE St, Winter Haven, FL 33880 in Polk County. The practice phone is (863) 293-2147.

Dr. Dewberry's primary practice is Florida Dermatology & Skin Cancer Centers in Winter Haven, Florida. The medical group on file is Florida Dermatology and Skin Cancer Centers. Dmand AI also links Dr. Dewberry to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dewberry practices. Vendor and product names are available with a free account.

Dermatology is Dr. Dewberry's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dewberry is board certified in 2002 - 2026 by the FL State License. Dr. Dewberry is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Dewberry treats.

CMS data shows 5,837 Medicare services from Dr. Dewberry across 17 procedure codes in 2024, for 1,075 Medicare patients. Medicare paid $235,266 for them. Every service was in an office.

CMS counts 1,075 Medicare patients who saw Dr. Dewberry in 2024. The largest group is 65 to 74, with 474 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dewberry's median patient age at 76, with 47% women.

In 2024, Dr. Dewberry wrote 1,361 Medicare Part D claims for 606 patients. 94% of them were for generic drugs. CMS names the drug for 1,163 of them, across 22 drugs with 11 or more claims each, at $321,667 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Dewberry for performance year 2024, reported individually. Dr. Dewberry accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 671 procedures of skin biopsy by Dr. Dewberry, more than 97% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Dewberry.

CMS Open Payments shows 6 general payments to Dr. Dewberry from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $39.

Dmand AI lists 1 award for Dr. Dewberry, most recently CMS Stage 1 EHR in 2013.

Dr. Dewberry graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 2000. Dr. Dewberry is a member of AOA.

Dr. Dewberry is in network with 16 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.